ENTRY       D11307                      Drug
NAME        Telisotuzumab (USAN)
FORMULA     C6440H9978N1724O2022S50
EXACT_MASS  145417.6987
MOL_WEIGHT  145507.7209
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYIFT AYTMHWVRQA PGQGLEWMGW IKPNNGLANY
            AQKFQGRVTM TRDTSISTAY MELSRLRSDD TAVYYCARSE ITTEFDYWGQ GTLVTVSSAS
            TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
            YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKRVEPKS CDCHCPPCPA PELLGGPSVF
            LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
            VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD 1GSFFLYSKLT
            VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPG
            (Light chain)
            DIVMTQSPDS LAVSLGERAT INCKSSESVD SYANSFLHWY QQKPGQPPKL LIYRASTRES
            GVPDRFSGSG SGTDFTLTIS SLQAEDVAVY YCQQSKEDPL TFGGGTKVEI KRTVAAPSVF
            IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (Disulfide bridge: H22-H96, H145-H201, H221-L218, H225-H'225, H228-H'228, H260-H320, H366-H424, H'22-H'96, H'145-H'201, H'221-L'218, H'260-H'320, H'366-H'424, L23-L92, L138-L198, L'23-L'92, L'138-L'198)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-MET antibody
  TYPE      Monoclonal antibody
TARGET      MET [HSA:4233] [KO:K05099]
  PATHWAY   hsa01521(4233)  EGFR tyrosine kinase inhibitor resistance
            hsa04510(4233)  Focal adhesion
            hsa04520(4233)  Adherens junction
            hsa05200(4233)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               MET family
                MET
                 D11307  Telisotuzumab (USAN)
DBLINKS     CAS: 1781223-80-0
            PubChem: 384585285
///
